Nikhil Agrawal (@nikhilrenal) 's Twitter Profile
Nikhil Agrawal

@nikhilrenal

Therapeutics and biomarkers development in Nephrology. Former Faculty BIDMC, Harvard Medical School. @landmark_neph, @Glomcon Fellows Curriculum co-creator

ID: 903635444562264065

calendar_today01-09-2017 15:07:33

466 Tweet

1,1K Takipçi

771 Takip Edilen

Nikhil Agrawal (@nikhilrenal) 's Twitter Profile Photo

Thank you for placing Beth Israel Lahey Health at the top of this graphic ;) But in all sincerity, thank you for getting this done and getting this done well. You are an awesome leader Leonardo V. Riella.

Prabir Roy Chaudhury (@proychaudhurymd) 's Twitter Profile Photo

A great MUST READ piece in “The Hill” by Anupam Agarwal President American Society of Nephrology highlighting the passion, intellectual strength and contributions of IMGs and also the challenges that we face. Thank you American Society of Nephrology for your support of IMGs UNC Kidney Center Swapnil Hiremath @hswapnil.medsky.social thehill.com/opinion/health…

Nikhil Agrawal (@nikhilrenal) 's Twitter Profile Photo

Final results from the poll. Looks like 2/3 don't do it ever. Others do it more in transplant and in high risk cases. Thank you for participating.

ASN Publications (@asnpublications) 's Twitter Profile Photo

2020 Editors’ Choice Article: Recurrence of FSGS after Kidney Transplantation in Adults. Idiopathic FSGS recurs post-transplant in a third of cases and is associated with a 5-fold higher risk of graft loss. bit.ly/CJN08970719

2020 Editors’ Choice Article: Recurrence of FSGS after Kidney Transplantation in Adults. Idiopathic FSGS recurs post-transplant in a third of cases and is associated with a 5-fold higher risk of graft loss. bit.ly/CJN08970719
Nikhil Agrawal (@nikhilrenal) 's Twitter Profile Photo

Super excited and thrilled to be a part of CareDx® family. Looking forward to working with this highly talented team to further improve transplant care.

KIReports (@kireports) 's Twitter Profile Photo

Cardiac outcomes in isolated heart and simultaneous kidney and heart transplants in the US #visualabstract #graphicalabstract by Krithika Mohan Krishna A. Agarwal Nikhil Agrawal Het Patel doi.org/10.1016/j.ekir…

Cardiac outcomes in isolated heart and simultaneous kidney and heart transplants in the US

#visualabstract #graphicalabstract by <a href="/krithicism/">Krithika Mohan</a> 

<a href="/krishnaadit/">Krishna A. Agarwal</a> <a href="/NikhilRenal/">Nikhil Agrawal</a> <a href="/hetpatel2006/">Het Patel</a>

doi.org/10.1016/j.ekir…
ASN Publications (@asnpublications) 's Twitter Profile Photo

In patients with kidney failure due to IgA nephropathy, IgA deposits can recur in a kidney transplant. This study found that cumulative risk of IgA nephropathy recurrence increased after transplant and was associated with a greater risk of graft loss bit.ly/CJN00910121

In patients with kidney failure due to IgA nephropathy, IgA deposits can recur in a kidney transplant. This study found that cumulative risk of IgA nephropathy recurrence increased after transplant and was associated with a greater risk of graft loss bit.ly/CJN00910121
CareDx® (@caredx) 's Twitter Profile Photo

See how CareDx’s “AlloCell” is assisting developers of allogeneic cell therapies to non-invasively monitor the expansion and persistence of their cell therapies in development. Learn more—bit.ly/3yljExV #allocell

CareDx® (@caredx) 's Twitter Profile Photo

Learn more about CareDx's planned AI clinical decision support tool for allograft risk assessments. Read more: bit.ly/3uIWoYi

Learn more about CareDx's planned AI clinical decision support tool for allograft risk assessments. 
Read more: bit.ly/3uIWoYi
CareDx® (@caredx) 's Twitter Profile Photo

Establishment And Validation of a Predictive Model for Differential Rejection Diagnosis by GEP in Renal Allograft Biopsies Using B-HOT Gene Panel. Explore the data here: bit.ly/3nXz05J

Establishment And Validation of a Predictive Model for Differential Rejection Diagnosis by GEP in Renal Allograft Biopsies Using B-HOT Gene Panel. 
Explore the data here: bit.ly/3nXz05J
CareDx® (@caredx) 's Twitter Profile Photo

Elevated Donor-Derived Cell-Free DNA (dd-cfDNA) in the Early Post-Transplant Period is Associated with an Increased Incidence of Adverse Clinical Outcomes in Kidney Transplant Recipients. Read more: bit.ly/3PpB2qW #ddcfDNA #transplanttwitter

Elevated Donor-Derived Cell-Free DNA (dd-cfDNA) in the Early Post-Transplant Period is Associated with an Increased Incidence of Adverse Clinical Outcomes in Kidney Transplant Recipients. 
Read more: bit.ly/3PpB2qW 
#ddcfDNA #transplanttwitter
CareDx® (@caredx) 's Twitter Profile Photo

Join CareDx at CEoT 2023 to learn the latest on integrating molecular tools and artificial intelligence into your clinical practice to advance transplant care and hear from this panel of experts. To learn more and register, visit bit.ly/3XzVp8n #ceot2023

Join CareDx at CEoT 2023 to learn the latest on integrating molecular tools and artificial intelligence into your clinical practice to advance transplant care and hear from this panel of experts. To learn more and register, visit bit.ly/3XzVp8n
#ceot2023
CareDx® (@caredx) 's Twitter Profile Photo

Great turnout at CareDx's Breakfast Symposium at #CEoT2023 in Scottsdale yesterday! Panel members shared the latest data on integrating molecular tools & artificial intelligence into clinical practice to advance tx care. If in attendance, be sure to stop by the CareDx booth!

Great turnout at CareDx's Breakfast Symposium at #CEoT2023 in Scottsdale yesterday! Panel members shared the latest data on integrating molecular tools &amp; artificial intelligence into clinical practice to advance tx care. If in attendance, be sure to stop by the CareDx booth!
CareDx® (@caredx) 's Twitter Profile Photo

The American Society of Transplant Surgeons Position Statement Supports Use of CareDx's AlloSure Kidney for Organ Transplant Surveillance—read more: bit.ly/3YlXg16

The American Society of Transplant Surgeons Position Statement Supports Use of CareDx's AlloSure Kidney for Organ Transplant Surveillance—read more: bit.ly/3YlXg16